摘要
目的评价应用肺表面活性物质对新生儿呼吸窘迫综合征进行治疗的临床效果。方法将2018年2月至2019年10月到我院进行治疗的200例新生儿呼吸窘迫综合征患儿应用抽签法则分为观察组和对照组,均为100例。对两组患儿均进行常规的基础治疗,观察组配合猪肺磷脂注射液治疗,对照组患儿应用牛肺磷脂注射液治疗,分别比较两组FiO2、PIP、PEEP值差异性情况。结果经过不同方法治疗后,观察组患儿的机械通气参数(FiO2、PIP、PEEP)均低于对照组,差异存在统计学意义(P<0.05)。结论对新生儿呼吸窘迫综合征在常规治疗基础之上应用肺表面活性物质猪肺磷脂注射液所取得的效果优于肺表面活性物质牛肺磷脂注射液,值得推荐。
Objective To evaluate the clinical effect of the application of pulmonary surfactants in the treatment of neonatal respiratory distress syndrome.Methods Two hundred children with neonatal respiratory distress syndrome who came to our hospital for treatment from February 2018 to October 2019 were divided into observation group and control group,both of which were 100 cases.The two groups of children were treated with conventional basic treatment.The observation group was treated with porcine alfamycin injection,and the control group was treated with bovine alfamycin injection.Compare the differences of FiO2,PIP,PEEP values between the two groups.Results After treatment with different methods,the mechanical ventilation parameters(FiO2,PIP,PEEP)of the observation group were lower than those of the control group,and the difference was statistically significant(P<0.05).Conclusion On the basis of conventional treatment of neonatal respiratory distress syndrome,the effect of pulmonary surfactant porcine alfa phospholipid injection is better than that of pulmonary surfactant bovine pulmonary phospholipid injection,which is worth recommending.
作者
罗楠
LUO Nan(Liaoning Fuxin Second People's Hospital(Fuxin Maternity Hospital),Fuxin 123000,China)
出处
《中国医药指南》
2021年第22期87-88,共2页
Guide of China Medicine
